1-4 of 4
Sarah Patches
Close
Save search
Sort by
Journal Articles

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Free
Omar Nadeem, Robert A. Redd, Trevor J. Bayliss, Peter Barth, Jacob Laubach, Clifton C. Mo, Giada Bianchi, Kelly Masone, Kyle Griffin, Lindsay Issokson, Anna Barrell, Randi Doherty, Deborah Mailand, Alexandra Distaso, Sarah Patches, Kathryn Goodrich, Kathleen Oneill, Vaishali Sanchorawala, Leyla O. Shune, Paul G. Richardson
Journal: Blood
Blood (2022) 140 (Supplement 1): 10180–10181.
https://doi.org/10.1182/blood-2022-165512
Published: 2022
Journal Articles

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Free
Omar Nadeem, Robert A. Redd, Peter Barth, Clifton C Mo, Jacob P. Laubach, Giada Bianchi, Trevor J. Bayliss, Vaishali Sanchorawala, Leyla Shune, Alexandra Distaso, Virginia Dalton, Mary McKenney, Sarah Patches, Isabella Hou, Lindsay Issokson, Anna Barrell, Kelly Masone, Adam S. Sperling, Nikhil C. Munshi, Irene M. Ghobrial, Kenneth C. Anderson, Paul G. Richardson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2021-146866
Published: 2021
Journal Articles

Survival Advantage to Allogeneic Transplant in Patients with Myelofibrosis with Intermediate-1 or Higher DIPSS Score

Free
Krisstina L. Gowin, DO, Karen K. Ballen, MD, Kwang Woo Ahn, PhD, Zhen-Huan Hu, MPH, Ying Liu, PhD, Lucia Masarova, MD, Srdan Verstovsek, MD PhD, Maria Coakley, Tania Jain, MBBS, Andrew Kuykendall, MD, Rami Komrokji, MD, Martha Wadleigh, MD, Sarah Patches, Murat Arcasoy, MD, Michael Green, Malathi Kandarpa, PhD, Moshe Talpaz, MD, Haris Ali, MD, Vikas Gupta, MD FRCP, FRCPath, Rebecca Devlin, Laura C. Michaelis, MD, Gabriela S. Hobbs, MD, Brady Lee Stein, MD, Ashley Pariser, MD, Aaron T. Gerds, MDMS, Kierstin Kuber, Raajit Rampal, Edwin P. Alyea, III, MD, Uday Popat, MD, Ronald Sobecks, MD, Bart L Scott, MD, Ruben Mesa, MD, Wael Saber, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4288.
https://doi.org/10.1182/blood-2018-99-119002
Published: 2018
Journal Articles

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

Free
Sarah Nikiforow, MD PhD, Lillian Werner, Joana Murad, PhD, Matthew Jacobs, Lauren Johnston, Sarah Patches, Randie White, Heather Daley, Helene Negre, PhD, Jake Reder, PhD, Charles Sentman, PhD, Terri Wade, MS, Adam Schmucker, MS, Frédéric François Lehmann, MD, Sarah Snykers, PhD, Rachel Allen, RN, MPH, Heidi Dipietro, RN, BSN, Kristen Cummings, RN, BSN, Ilene Galinsky, MSN, ANPc, Nikhil C. Munshi, MD, Robert L. Schlossman, MD, Richard M. Stone, MD, Donna S. Neuberg, ScD, Robert J. Soiffer, MD, Glenn Dranoff, MD, Jerome Ritz, MD, Susanne H.C. Baumeister, MD
Journal: Blood
Blood (2016) 128 (22): 4052.
https://doi.org/10.1182/blood.V128.22.4052.4052
Published: 2016